Article
Consultation On Proposed Interim Approach To Reduce Review Timeline To 180 Days For Certain Pediatric Drugs
On September 14, 2026, Health Canada launched a consultation seeking public feedback on a proposed “new interim approach to speed up the review of certain pediatric drugs”, including on the proposed eligibility criteria and review timelines.
Smart & Biggar